期刊文献+

氧自由基与应激性肠黏膜屏障损伤 被引量:2

Oxygen Free Radicals and Stress-related Intestinal Mucosa Damage
下载PDF
导出
摘要 氧自由基和人类大部分疾病相关。严重应激状态下存在肠黏膜损伤,在其复杂的发病机制中,氧自由基是其中的一个重要因素。本文主要概述氧自由基在应激性肠黏膜损伤中的作用。 Oxygen free radicals (OFRs) involve in the pathogenesis of many diseases. Severe stress can result in intestinal mucosa damage, in which OFRs play an important role. The article reviews the effect of OFRs in the process of stress-related mucosa damage.
出处 《中国临床营养杂志》 2008年第5期310-315,共6页 Chinese Journal of Clinical Nutrition
关键词 氧自由基 肠黏膜损伤 oxygen free radicals intestinal mueosa damage
  • 相关文献

参考文献14

二级参考文献144

共引文献222

同被引文献24

  • 1陈俐彤,曹红峰,黄文芳.蛹虫草的化学成分、药效及应用[J].现代食品科技,2005,21(3):192-194. 被引量:50
  • 2黄智勇,曾国琼,谭旭东,林源泉.血小板激活与活动期发生溃疡性结肠炎的关系[J].中国基层医药,2006,13(3):386-387. 被引量:6
  • 3王燕斌,梁丕霞,朱玉群,杨昭徐.大鼠创伤性脑损伤后肠黏膜屏障的应激性变化[J].中华消化杂志,2007,27(2):103-106. 被引量:11
  • 4Smalheiser NR, Torvik VI, Weeber M, Swanson DR. The Arrowsmith Project: New Tools to assist Biomedical Discovery and Collaboration, presented at the Beckman Institute, University of Illinois at Urbana- Champaign, October 1, 2002. 被引量:1
  • 5Menassa R,Du C, Yin ZQ. Therapeutic effectiveness of orally administered transgenic low2alkaloid tobacco exp ressing human interleukin- 10 in a mouse model of colitis. Plant Biotechnol J,2007, 5 (1) : 50 - 59. 被引量:1
  • 6Zhou X, Luo L, Dressel W, Shadier G, Krumbiegel D, Schmidtke P, Zepp F, Meyer CU.Cordycepin is an immunoregulatory active ingredient of Cordyeeps sinensis. Am J Chin Med. 2008;36(5):967-80. 被引量:1
  • 7HanX,FinkMP,DeludeRL.Proinflamma torycylokines cause NO dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock,2003,19 (3) :229- 237. 被引量:1
  • 8Kim H G, Sh restha B, L im S Y.Cordycepin inhibits lipopolysaccharide induced inflammation by the suppression of NF2 kappaB through Akt and p38 inhibition in RAW 264. 7 macrophage cells [J ]. Eur J Pharmacol, 2006, 545 (223) :192-199 . 被引量:1
  • 9Danese S, Motte Cd Cde L, Fiocchi C.Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol. 2004, 99(5):938-945. 被引量:1
  • 10Carry E ,Macey M ,McCartney SA. Ridogrel ,a dual thromboxane synthase inhibitor and receptor antagonist : anti-inflammatory proffie in inflammatory bowel disease. Aliment Pharmacol Ther,2000,14:807-817. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部